THE RESOLUTE ZOTAROLIMUS-ELUTING STENT IN PATIENTS WIH DIABETES MELLITUS: TWO YEAR OUTCOMES

Alan C. Yeung; Martin B. Leon; Sigmund Silber; Patrick W. Serruys; Stephan Windecker; Jorge Belardi; Ian T. Meredith; Franz ndash Josef Neumann; Petr Widimský; Shigeru Saito; Joseph M. Massaro; Laura Mauri

doi:10.1016/s0735-1097(12)60098-9

Related publications

Article2012

TCT-639 Two Year Outcomes Following Implantation of the Resolute Zotarolimus-eluting Stent in Vessels ≤2.5 mm Diameter

Ronald Caputo, Martin B. Leon, Patrick W. Serruys, Franz‐Josef Neumann, Alan C. Yeung, Stephan Windecker, Jorge Belardi, Sigmund Silber, Ian T. Meredith, Petr Widimský, Shigeru Saito, Laura Mauri

Journal of the American College of Cardiology

Article2018

TCT-137 Five-Year Clinical Outcomes for Resolute Zotarolimus-Eluting Stents in Total Occlusions

Robert W. Yeh, Henning Kelbæk, Franz‐Josef Neumann, Patrick W. Serruys, Stephan Windecker, Jorge Belardi, Bo Xu, Shubin Qiao, Minglei Liu, Sigmund Silber

Journal of the American College of Cardiology

Article2020

BuMA Supreme biodegradable polymer sirolimus-eluting stent versus a durable polymer zotarolimus-eluting coronary stent: three-year clinical outcomes of the PIONEER trial

Chun Chin Chang, Norihiro Kogame, Taku Asano, Clemens von Birgelen, Manel Sabaté, Yoshinobu Onuma, Patrick W. Serruys

EuroIntervention

Article2013

Clinical Outcomes of the Resolute Zotarolimus-Eluting Stent in Patients With In-Stent Restenosis

Gert Richardt, Matthias Leschke, Mohamed Abdel‐Wahab, Ralph Töelg, Mohamed El‐Mawardy, Patrick W. Serruys, Sigmund Silber, Stephan Windecker, Jorge Belardi, Franz‐Josef Neumann, Petr Widimský

КАРДИОЛОГИЯ УЗБЕКИСТАНА

Article2013

THE RELATIONSHIP BETWEEN SHORT AND LONG–TERM ANTIPLATELET THERAPY USE AND STENT THROMBOSIS FOLLOWING PERCUTANEOUS CORONARY INTERVENTION WITH THE RESOLUTE ZOTAROLIMUS–ELUTING STENT

Ajay J. Kirtane, Sigmund Silber, Franz‐Josef Neumann, Patrick W. Serruys, Laura Mauri, Ian T. Meredith, Stephan Windecker, Jorge Belardi, Petr Widimský, Alan C. Yeung, Shigeru Saito, Martin B. Leon

Journal of the American College of Cardiology

THE RESOLUTE ZOTAROLIMUS-ELUTING STENT IN PATIENTS WIH DIABETES MELLITUS: TWO YEAR OUTCOMES

Abstract

Discussion(0)

Related publications

TCT-639 Two Year Outcomes Following Implantation of the Resolute Zotarolimus-eluting Stent in Vessels ≤2.5 mm Diameter

TCT-137 Five-Year Clinical Outcomes for Resolute Zotarolimus-Eluting Stents in Total Occlusions

BuMA Supreme biodegradable polymer sirolimus-eluting stent versus a durable polymer zotarolimus-eluting coronary stent: three-year clinical outcomes of the PIONEER trial

Clinical Outcomes of the Resolute Zotarolimus-Eluting Stent in Patients With In-Stent Restenosis

THE RELATIONSHIP BETWEEN SHORT AND LONG–TERM ANTIPLATELET THERAPY USE AND STENT THROMBOSIS FOLLOWING PERCUTANEOUS CORONARY INTERVENTION WITH THE RESOLUTE ZOTAROLIMUS–ELUTING STENT